PMTMEDIUM SIGNALFINANCIAL10-K

PMT substantially expanded its balance sheet while experiencing meaningfully higher interest expenses that compressed net income despite revenue growth.

The company appears to be in a growth phase, significantly expanding its asset base while maintaining profitability, though at reduced margins due to higher financing costs. The substantial increase in liabilities alongside asset growth suggests increased leverage to fund expansion, which introduces additional financial risk but could drive future returns if deployed effectively.

Comparing 2026-02-18 vs 2025-02-20View on EDGAR →
FINANCIAL ANALYSIS

PMT's financials reflect aggressive balance sheet expansion, with total assets growing 48% to $21.3B and liabilities increasing 56% to $19.5B, indicating higher leverage ratios. While revenue grew a solid 10% to $351M, interest expenses rose substantially to $736M, compressing net income by 21% to $128M and reflecting the cost of financing this expansion. The company reduced dividend payments by 24% to $132M, likely preserving capital to support the enlarged balance sheet, while cash declined modestly to $60M.

FINANCIAL STATEMENT CHANGES
Interest Expense
P&L
+79.3%
$410.4M$736.0M

Interest expense surged 79.3% — significant debt increase or rising rates materially impacting earnings.

Total Liabilities
Balance Sheet
+56%
$12.5B$19.5B

Liabilities grew 56% — significant increase in debt or obligations, assess impact on financial flexibility.

Total Assets
Balance Sheet
+48.2%
$14.4B$21.3B

Asset base grew 48.2% — expansion through organic growth, acquisitions, or capital deployment.

Dividends Paid
Cash Flow
-24%
$173.0M$131.6M

Dividend reduced 24% — monitor management commentary on capital allocation priorities.

Cash & Equivalents
Balance Sheet
-22.9%
$77.6M$59.8M

Cash decreased 22.9% — monitor burn rate and upcoming capital needs.

Net Income
P&L
-20.6%
$161.0M$127.9M

Net income declined 20.6% — review whether driven by operations, interest costs, or non-recurring items.

Revenue
P&L
+10.4%
$317.9M$351.1M

Revenue growing 10.4% — solid top-line momentum, watch margins for quality of growth.

LANGUAGE CHANGES
NEW — 2026-02-18
PRIOR — 2025-02-20
ADDED
As of February 13, 2026, there were 87,016,604 comm on shares of the registrant outstanding.
We also invest in Agency and senior non-Agency MBS, subordinate MBS, interest-only ("IO"), principal-only ("PO") stripped MBS and Agency floating rate collateralized mortgage obligations ("CMOs").
A significant portion of our business involves Government-Sponsored Enterprises ("GSEs"), specifically the Federal Home Loan Mortgage Corporation ("Freddie Mac") and the Federal National Mortgage Association ("Fannie Mae").
Freddie Mac and Fannie Mae are each referred to as an Agency and, collectively as the "Agencies".
We operate our business in three segments: credit sensitive strategies, interest rate sensitive strategies and correspondent production.
+7 more — sign up free →
REMOVED
As of February 17, 2025, there were 86,860,960 common shares of the registrant outstanding.
We also invest in Agency and senior non-Agency MBS, subordinate credit-linked MBS and interest-only ("IO") and principal-only ("PO") stripped MBS.
We have also historically invested in distressed mortgage assets (distressed loans and real estate acquired in settlement of loans ( REO )), which we have substantially liquidated.
Our business includes three segments: credit sensitive strategies, interest rate sensitive strategies and correspondent production.
The interest rate sensitive strategies segment represents our investments in MSRs (including both base servicing and excess servicing spread ( ESS ), collectively referred to as MSR), Agency and senior non-Agency MBS and the related interest rate hedging activities.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →